Steven Maslowski

Steven Maslowski

Akin Gump Strauss Hauer & Feld LLP

Contact
View Bio
RSS

Latest Posts › Food and Drug Administration (FDA)

Share:

Federal Circuit: Patent Term Adjustment Results in Invalidity on Obviousness-Type Double Patenting Grounds

The Federal Circuit recently affirmed a United States Patent and Trademark Office (PTO) decision to invalidate four related patents on obviousness-type double patenting grounds (OTDP), holding that any analysis of OTDP for...more

9/1/2023  /  Appeals , Ex Partes Reexamination , Food and Drug Administration (FDA) , Obviousness-Type Double Patenting (ODP) , Patent Invalidity , Patent Term Adjustment , USPTO
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide